Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JN002 in Dry Eye Disease
NCT07245017Phase 1Recruiting
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Nov 2025
- Primary completion
- Mar 2026
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of JN002 in dry eye disease (DED) (3 arms), sponsored by Eye and ENT Hospital of Fudan University. Primary endpoints: Corneal Fluorescein Staining Score at 28 days and Ocular Surface Disease Index Score at 28 days. Started Nov 2025; status: recruiting.
02
Drugs
JN002
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07245017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07245017.